Extending the nosology of the chondrodysplasias to the cellular and molecular levels
- PMID: 7700716
- DOI: 10.1007/BF02011906
Extending the nosology of the chondrodysplasias to the cellular and molecular levels
Abstract
Rapid advances in molecular genetics have created and will continue to create problems in the classification of human bone dysplasias. It is proposed that the functional significance of mutations be taken into account in future nosologies for these disorders. Chondrocyte culture and transgenic mouse strategies are briefly discussed as approaches to evaluating the functional consequences of chondrodysplasia mutations on skeletel development and growth.
Similar articles
-
The evolving definition of a chondrodysplasia?Pediatr Pathol Mol Med. 2003 Jan-Feb;22(1):47-52. doi: 10.1080/pdp.22.1.47.52. Pediatr Pathol Mol Med. 2003. PMID: 12687889 Review.
-
Transgenic mouse models in studies of skeletal disorders.J Rheumatol Suppl. 1995 Feb;43:39-41. J Rheumatol Suppl. 1995. PMID: 7752133
-
Molecular genetics of chondrodysplasias, including clues to development, structure, and function.Curr Opin Rheumatol. 1994 May;6(3):345-50. doi: 10.1097/00002281-199405000-00018. Curr Opin Rheumatol. 1994. PMID: 8060773 Review.
-
The comparative biology of chondrodysplasias in mice.Pathol Immunopathol Res. 1988;7(1-2):55-61. doi: 10.1159/000157094. Pathol Immunopathol Res. 1988. PMID: 3222208
-
Some chondrodysplasias with short limbs: molecular perspectives.Am J Med Genet. 2002 Oct 15;112(3):304-13. doi: 10.1002/ajmg.10780. Am J Med Genet. 2002. PMID: 12357475 Review.
Cited by
-
Effect of tetramethylpyrazine on tibial dyschondroplasia incidence, tibial angiogenesis, performance and characteristics via HIF-1α/VEGF signaling pathway in chickens.Sci Rep. 2018 Feb 6;8(1):2495. doi: 10.1038/s41598-018-20562-3. Sci Rep. 2018. PMID: 29410465 Free PMC article.